New Delhi, February 12 Biocon announced on Thursday a more than five-fold increase in consolidated net profit to Rs 144 crore for the quarter ended December 2025, driven by gains in its generics and biosimilar business segments.The Bengaluru-based company reported a net profit of Rs 25 crore...